A circulating protein signature for predicting severe immune-related adverse events following CAR T-cell therapy in relapsed/refractory lymphoma
一种用于预测复发/难治性淋巴瘤患者接受 CAR-T 细胞治疗后严重免疫相关不良事件的循环蛋白特征
期刊:
影响因子:
doi:10.64898/2026.03.29.26349664
Irajizad, Ehsan; Fahrmann, Johannes F; Katayama, Hiroyuki; Strati, Paolo; Nair, Ranjit; Chihara, Dai; Fayad, Luis E; Ahmed, Sairah; Iyer, Swaminathan P; Wang, Michael; Locke, Frederick L; Davila, Marco; Flowers, Christopher R; Shpall, Elizabeth; Neelapu, Sattva S; Hanash, Samir; Westin, Jason; Jain, Michael D; John, Teny M; Saini, Neeraj Y